5if4
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) inhibitors using Structure-Based Design== | ==Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) inhibitors using Structure-Based Design== | ||
| - | <StructureSection load='5if4' size='340' side='right' caption='[[5if4]], [[Resolution|resolution]] 2.39Å' scene=''> | + | <StructureSection load='5if4' size='340' side='right'caption='[[5if4]], [[Resolution|resolution]] 2.39Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[5if4]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5IF4 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5IF4 FirstGlance]. <br> | <table><tr><td colspan='2'>[[5if4]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5IF4 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5IF4 FirstGlance]. <br> | ||
| Line 20: | Line 20: | ||
</div> | </div> | ||
<div class="pdbe-citations 5if4" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 5if4" style="background-color:#fffaf0;"></div> | ||
| + | |||
| + | ==See Also== | ||
| + | *[[B-cell lymphoma proteins 3D structures|B-cell lymphoma proteins 3D structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
| Line 25: | Line 28: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Human]] | [[Category: Human]] | ||
| + | [[Category: Large Structures]] | ||
[[Category: Zhao, B]] | [[Category: Zhao, B]] | ||
[[Category: Apoptosis]] | [[Category: Apoptosis]] | ||
Revision as of 09:07, 4 December 2019
Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) inhibitors using Structure-Based Design
| |||||||||||
